ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 1999-07, Vol.106 (1), p.252-253
Hauptverfasser:	Aydinok, Y, Nisli, G, Kavakli, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent beta-Thalassemia - drug therapy Chelating Agents - therapeutic use Child Deferiprone Deferoxamine - therapeutic use Humans Iron Chelating Agents - therapeutic use Pyridones - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	253
container_issue	1
container_start_page	252
container_title	British journal of haematology
container_volume	106
creator	Aydinok, Y Nisli, G Kavakli, K
description
doi_str_mv	10.1046/j.1365-2141.1999.01560.x
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69963291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69963291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4150-e6d91bcaea9cb1f87978a30461864b181705ccef4bcee4848a519ca508ca576c3</originalsourceid><addsrcrecordid>eNqNkMFv2jAUxq1q06Dt_oXJp92S-TWOYx928MAsRiGpklTdTlZijASCQZOh0f--TkHVjr3Yfp-_7z29H0IYSAiEsm-bECIWB3dAIQQhREggZiQ8XaHx28cHNCaEJIEP8BG67vsNIRCRGD6hkdcoBcHGyMqsVmUua4UfKoWLGZ6qmSr1fVnkCst86uvKC6UufsmF9prO8X2pF7L8jatJWhQZnqQ6m5Yqx4-6TnGdykxWlVQLLfFCzovyFn1cNdvefb7cN-hhpupJGmTFTz2RWWApxCRwbCmgtY1rhG1hxROR8Cby6wJntAUOCYmtdSvaWucop7yJQdgmJtwfCbPRDfp67nvo9k9H1_81u3Vv3Xbb_HH7Y2-YECy6E-CN_Gy03b7vO7cyh269a7pnA8QMgM3GDBzNwNEMgM0rYHPy0S-XGcd255b_Bc9EveH72fBvvXXP725sfszT4RW9APRZgKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69963291</pqid></control><display><type>article</type><title>ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Aydinok, Y ; Nisli, G ; Kavakli, K</creator><creatorcontrib>Aydinok, Y ; Nisli, G ; Kavakli, K</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1046/j.1365-2141.1999.01560.x</identifier><identifier>PMID: 10444196</identifier><language>eng</language><publisher>Oxford, U.K. and Cambridge, USA: Blackwell Science Ltd</publisher><subject>Adolescent ; beta-Thalassemia - drug therapy ; Chelating Agents - therapeutic use ; Child ; Deferiprone ; Deferoxamine - therapeutic use ; Humans ; Iron Chelating Agents - therapeutic use ; Pyridones - therapeutic use ; Treatment Outcome</subject><ispartof>British journal of haematology, 1999-07, Vol.106 (1), p.252-253</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4150-e6d91bcaea9cb1f87978a30461864b181705ccef4bcee4848a519ca508ca576c3</citedby><cites>FETCH-LOGICAL-c4150-e6d91bcaea9cb1f87978a30461864b181705ccef4bcee4848a519ca508ca576c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2141.1999.01560.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2141.1999.01560.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10444196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aydinok, Y</creatorcontrib><creatorcontrib>Nisli, G</creatorcontrib><creatorcontrib>Kavakli, K</creatorcontrib><title>ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Adolescent</subject><subject>beta-Thalassemia - drug therapy</subject><subject>Chelating Agents - therapeutic use</subject><subject>Child</subject><subject>Deferiprone</subject><subject>Deferoxamine - therapeutic use</subject><subject>Humans</subject><subject>Iron Chelating Agents - therapeutic use</subject><subject>Pyridones - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMFv2jAUxq1q06Dt_oXJp92S-TWOYx928MAsRiGpklTdTlZijASCQZOh0f--TkHVjr3Yfp-_7z29H0IYSAiEsm-bECIWB3dAIQQhREggZiQ8XaHx28cHNCaEJIEP8BG67vsNIRCRGD6hkdcoBcHGyMqsVmUua4UfKoWLGZ6qmSr1fVnkCst86uvKC6UufsmF9prO8X2pF7L8jatJWhQZnqQ6m5Yqx4-6TnGdykxWlVQLLfFCzovyFn1cNdvefb7cN-hhpupJGmTFTz2RWWApxCRwbCmgtY1rhG1hxROR8Cby6wJntAUOCYmtdSvaWucop7yJQdgmJtwfCbPRDfp67nvo9k9H1_81u3Vv3Xbb_HH7Y2-YECy6E-CN_Gy03b7vO7cyh269a7pnA8QMgM3GDBzNwNEMgM0rYHPy0S-XGcd255b_Bc9EveH72fBvvXXP725sfszT4RW9APRZgKw</recordid><startdate>199907</startdate><enddate>199907</enddate><creator>Aydinok, Y</creator><creator>Nisli, G</creator><creator>Kavakli, K</creator><general>Blackwell Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199907</creationdate><title>ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR</title><author>Aydinok, Y ; Nisli, G ; Kavakli, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4150-e6d91bcaea9cb1f87978a30461864b181705ccef4bcee4848a519ca508ca576c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>beta-Thalassemia - drug therapy</topic><topic>Chelating Agents - therapeutic use</topic><topic>Child</topic><topic>Deferiprone</topic><topic>Deferoxamine - therapeutic use</topic><topic>Humans</topic><topic>Iron Chelating Agents - therapeutic use</topic><topic>Pyridones - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aydinok, Y</creatorcontrib><creatorcontrib>Nisli, G</creatorcontrib><creatorcontrib>Kavakli, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aydinok, Y</au><au>Nisli, G</au><au>Kavakli, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>1999-07</date><risdate>1999</risdate><volume>106</volume><issue>1</issue><spage>252</spage><epage>253</epage><pages>252-253</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>Oxford, U.K. and Cambridge, USA</cop><pub>Blackwell Science Ltd</pub><pmid>10444196</pmid><doi>10.1046/j.1365-2141.1999.01560.x</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0007-1048
ispartof	British journal of haematology, 1999-07, Vol.106 (1), p.252-253
issn	0007-1048 1365-2141
language	eng
recordid	cdi_proquest_miscellaneous_69963291
source	MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals
subjects	Adolescent beta-Thalassemia - drug therapy Chelating Agents - therapeutic use Child Deferiprone Deferoxamine - therapeutic use Humans Iron Chelating Agents - therapeutic use Pyridones - therapeutic use Treatment Outcome
title	ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A43%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ALTERNATE%20USE%20OF%20DEFERIPRONE%20AND%20DESFERRIOXAMINE%20IN%20PRIMARY%20SCHOOL%20CHILDREN%20WITH%20THALASSAEMIA%20MAJOR&rft.jtitle=British%20journal%20of%20haematology&rft.au=Aydinok,%20Y&rft.date=1999-07&rft.volume=106&rft.issue=1&rft.spage=252&rft.epage=253&rft.pages=252-253&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1046/j.1365-2141.1999.01560.x&rft_dat=%3Cproquest_cross%3E69963291%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69963291&rft_id=info:pmid/10444196&rfr_iscdi=true